COVID-19 and patients with immune-mediated inflammatory diseases undergoing pharmacological treatments: a rapid living systematic review

BACKGROUND: Patients with immune-mediated inflammatory diseases (IMID) are at increased risk of infection. OBJECTIVE: To assess whether patients undergoing pharmacological treatment for IMID present higher risk of worse outcomes when diagnosed with COVID-19. DESIGN AND SETTING: Rapid systematic revi...

Descripción completa

Detalles Bibliográficos
Autores principales: da Rocha, Aline Pereira, Atallah, Álvaro Nagib, Pinto, Ana Carolina Pereira Nunes, Rocha-Filho, César Ramos, Milby, Keilla Martins, Civile, Vinicius Tassoni, Carvas, Nelson, Reis, Felipe Sebastião de Assis, Ferla, Laura Jantsch, Ramalho, Gabriel Sodré, Trevisani, Giulia Fernandes Moça, Puga, Maria Eduarda dos Santos, Trevisani, Virgínia Fernandes Moça
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Paulista de Medicina - APM 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685570/
https://www.ncbi.nlm.nih.gov/pubmed/33331606
http://dx.doi.org/10.1590/1516-3180.2020.0421.R2.10092020

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9685570/
https://www.ncbi.nlm.nih.gov/pubmed/33331606
http://dx.doi.org/10.1590/1516-3180.2020.0421.R2.10092020

Ejemplares similares